Results 201 to 210 of about 24,256 (259)

The potential for biased signalling in the P2Y receptor family of GPCRs

British Journal of Pharmacology, EarlyView.
The purinergic receptor family is primarily activated by nucleotides, and contains members of both the G protein coupled‐receptor (GPCR) superfamily (P1 and P2Y) and ligand‐gated ion channels (P2X). The P2Y receptors are widely expressed in the human body, and given the ubiquitous nature of nucleotides, purinergic signalling is involved with a plethora
Claudia M. Sisk, Simon Pitchford, Graham Ladds   +2 more
wiley   +1 more source

Microbiome characterization of patients with Crohn disease and the use of fecal microbiota transplantation: A review. [PDF]

Medicine (Baltimore)
Chen S, Zhang D, Li D, Zeng F, Chen C, Bai F.   +5 more
europepmc   +1 more source

Erratum for: Reliability of MR Enterography Features for Describing Fibrostenosing Crohn Disease. [PDF]

Radiology
Rieder F, Baker ME, Bruining DH, Fidler JL, Ehman EC, Sheedy SP, Heiken JP, Ream JM, Holmes DR, Inoue A, Mohammadinejad P, Lee YS, Taylor SA, Stoker J, Zou G, Wang Z, Rémillard J, Carter RE, Ottichilo R, Atkinson N, Siddiqui MT, Sunkesula VC, Ma C, Parker CE, Panés J, Rimola J, Jairath V, Feagan BG, Fletcher JG, Stenosis Therapy and Anti-Fibrosis Research (STAR) Consortium.   +29 more
europepmc   +1 more source

Emotional Care, Emotionless Decisions

Acta Paediatrica, EarlyView.
Danilo Buonsenso
wiley   +1 more source

Immune Repertoire Profiling Reveals Distinct Adaptive Immune Signatures of Dampness ZHENG Across Psoriasis, Rheumatoid Arthritis and Ulcerative Colitis

Cell Proliferation, EarlyView.
Schematic diagram for the experimental design for adaptome immune repertoire analysing Dampness ZHENG across Psoriasis, Rheumatoid Arthritis and Ulcerative Colitis. ABSTRACT Autoimmune diseases, including psoriasis (Ps), rheumatoid arthritis (RA) and ulcerative colitis (UC), pose significant health burdens worldwide.
Lipeng Tang, Maojie Wang, Yuhong Yan, Shumin Qin, Youbang Liang, Danni Yao, Liyan Mei, Hao Deng, Shuyan Ye, Xiumin Chen, Kaixin Gao, Xirun Zheng, Taohua Liu, Xinmin Qiu, Song Li, Xinjie Yu, Wenjing Pan, Shaogang Huang, Zhe Wang, Runyue Huang, Guangjuan Zheng, Chuanjian Lu   +21 more
wiley   +1 more source

Reliability of MR Enterography Features for Describing Fibrostenosing Crohn Disease. [PDF]

Radiology
Rieder F, Baker ME, Bruining DH, Fidler JL, Ehman EC, Sheedy SP, Heiken JP, Ream JM, Holmes DR, Inoue A, Mohammadinejad P, Lee YS, Taylor SA, Stoker J, Zou G, Wang Z, Rémillard J, Carter RE, Ottichilo R, Atkinson N, Siddiqui MT, Sunkesula VC, Ma C, Parker CE, Panés J, Rimola J, Jairath V, Feagan BG, Fletcher JG, Stenosis Therapy and Anti-Fibrosis Research (STAR) Consortium.   +29 more
europepmc   +1 more source

When Crohn's disease is not Crohn's disease.

North Carolina medical journal, 1985
D A, Forsberg, T C, Wall, J T, Garbutt
openaire   +1 more source

Intestinal tissue levels of anti-TNF alpha, antibodies, and cytokines in paediatric Crohn disease. [PDF]

Sci Rep
Dotlacil V, Coufal S, Lerchova T, Zarubova K, Kucerova B, Tlaskalova-Hogenova H, Kverka M, Skaba R, Bronsky J, Hradsky O, Rygl M.   +10 more
europepmc   +1 more source

First-line anti-TNF agents, ustekinumab and vedolizumab perform similarly in Crohn' disease, but not in ulcerative colitis. [PDF]

Eur J Gastroenterol Hepatol
Supovec E, Hanžel J, Novak G, Manevski D, Štabuc B, Drobne D.   +5 more
europepmc   +1 more source

Hematopoietic stem cell transplantation therapy for refractory' Crohn disease: A systematic review and meta-analysis. [PDF]

Medicine (Baltimore)
Serrano-Fernandez V, Serrano-Fernandez V, Carmona-Torres JM, Carmona-Torres JM, Arroyo-Rodriguez A, Lopez-Gonzalez A, Rabanales-Sotos J, Laredo-Aguilera JA.   +7 more
europepmc   +1 more source